H.O.P.E: Helping Ovarian Cancer Patients Cope
NCT02090582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47
Last updated 2020-05-13
Summary
The purpose of this study is to test the effect of the gynecologic oncologists with palliative care specialist collaboration (GO-PC) intervention on patient quality of life.
Conditions
- Platinum-resistant Ovarian Cancer
- Recurrent Ovarian Cancer
- Palliative Care
Interventions
- OTHER
-
Structured Palliative Care
Structured palliative care approach, defined as the gynecologic oncology team performing comprehensive symptom assessment with the Quality Data Collection Tool Palliative Care (QDACT-PC) and providing interventions based on National Comprehensive Cancer Network (NCCN) guidelines. Symptom scores above the acceptable threshold in the QDACT-PC tool that occur after two consecutive visits will automatically trigger palliative care consultation.
- OTHER
-
Usual Care
Usual care described as current practice by the gynecologic oncology team with referral to PC specialist at provider discretion or at the request of the patient or their families.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paula S Lee, MD · Duke University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- United States
Study Locations
More Related Trials
-
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
NCT01927393 ·Status: WITHDRAWN ·Phase: NA
-
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346 ·Status: COMPLETED ·Phase: NA
-
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
NCT01970722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma
NCT01177501 ·Status: TERMINATED ·Phase: PHASE1
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03188432 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02050009 ·Status: WITHDRAWN ·Phase: PHASE1
-
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
NCT00052468 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
NCT00005051 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
NCT00550784 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003064 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
NCT00003297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer
NCT01248962 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers
NCT01659554 ·Status: TERMINATED ·Phase: PHASE2
-
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00055614 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
NCT01709487 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3
-
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
NCT00214058 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
NCT00772798 ·Status: UNKNOWN ·Phase: PHASE2
-
A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
NCT05479045 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
NCT00910000 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
NCT00005612 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy
NCT04415944 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00004012 ·Status: COMPLETED ·Phase: PHASE2